After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Recently, Yahoo Finance discussed the stock, revealing that BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, BLFS falls under the Healthcare sector while operating within the Medical Instruments & Supplies industry segment. At the end of the last regular session, the stock closed at $17.52 and fluctuated between $17.57 as its day high and $16.70 as its day low. The current market capitalization of Biolife Solutions Inc is $789.28M. A total of 0.68 million shares were traded on the day, compared to an average of 559.56K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, BLFS has seen 17 BUY and 7 SELL insider trades, representing the acquisition of 1,365,736 and the disposition of 73,231 shares. Over the last 12 months, there were 74 BUYs and 116 SELLs from insiders. Insiders purchased 1,758,217 shares during that period but sold 321,295.
In the most recent transaction, Mathew Aby J. sold 697 shares of BLFS for 16.75 per share on Jan 02. After the transaction, the EVP & Chief Scientific Officer now owns 276,765 company shares. In a previous transaction on Jan 02, Foster Karen A. sold 601 shares at 16.75 per share. BLFS shares that Chief Quality and Operations owns now total 125,225.
Among the insiders who sold shares, Berard Todd disposed of 491 shares on Jan 02 at a per-share price of $16.75. This resulted in the Chief Marketing Officer holding 117,031 shares of BLFS after the transaction. In another insider transaction, Wichterman Troy sold 314 shares at $16.79 per share on Dec 22. Company shares held by the Chief Financial Officer now total 67,339.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for BLFS in the last 3 months, the mean price target is $23.29 with high estimates of $30.00 and low estimates of $20.00. In terms of 52-week highs and lows, BLFS has a high of $26.89 and a low of $8.92.
As of this writing, BLFS has an earnings estimate of $BRF S.A. per share for the current quarter. EPS was calculated based on a consensus of BioLife Solutions, Inc. estimates, with a high estimate of $BLUEFIRE EQUIPMENT CORPORATION per share and a lower estimate of $Saul Centers, Inc.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BLFS’s latest balance sheet shows that the firm has $69.86M in Cash & Short Term Investments as of fiscal 2021. There were $26.88M in debt and $42.70M in liabilities at the time. Its Book Value Per Share was $7.57, while its Total Shareholder’s Equity was $478.05M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BLFS is Buy with a score of 4.75.
